R2 relaxometry with MRI for the quantification of tissue iron overload in β-thalassemic patients

Journal of Magnetic Resonance Imaging

Volumn 23, Issue 2, 2006, Pages 163-170

  Alexopoulou, Efthymia ^a   Stripeli, Fotini ^a   Baras, Panagiotis ^b   Seimenis, Ioannis ^b   Kattamis, Antonis ^c   Ladis, Vasilis ^c   Efstathopoulos, Efstathios ^a   Brountzos, Elias N ^a   Kelekis, Alexis D ^a   Kelekis, Nikolaos L ^a,d  

^a UNIVERSITY OF ATHENS   (Greece)

^b PHILIPS HEALTHCARE   (United States)

^c AGHIA SOPHIA CHILDREN S HOSPITAL   (Greece)

^d NATIONAL AND KAPODISTRIAN UNIVERSITY OF ATHENS   (Greece)

Author keywords

Heart; Iron deposits; Liver; MR imaging; Thalassemia

Indexed keywords

CONTRAST MEDIUM; FERRITIN; GADOLINIUM PENTETATE;

ADOLESCENT; ADULT; ARTICLE; BETA THALASSEMIA; BLOOD TRANSFUSION; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FERRITIN BLOOD LEVEL; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MUSCLE; HISTOLOGY; HUMAN; IMAGING SYSTEM; IRON OVERLOAD; LIVER; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; SIGNAL NOISE RATIO; THALASSEMIA; TISSUE DISTRIBUTION;

ADOLESCENT; ADULT; ANALYSIS OF VARIANCE; BETA-THALASSEMIA; CASE-CONTROL STUDIES; CHILD; ECHO-PLANAR IMAGING; FEMALE; FERRITINS; HUMANS; IRON OVERLOAD; MAGNETIC RESONANCE IMAGING; MALE; PROBABILITY; REFERENCE VALUES; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX; SIGNAL PROCESSING, COMPUTER-ASSISTED; STROKE VOLUME;

EID: 31944446136     PISSN: 10531807     EISSN: None     Source Type: Journal    
DOI: 10.1002/jmri.20489     Document Type: Article

References (33)

1. Gabutti V, Borgna-Pignatti C. Clinical manifestations and therapy of transfusional haemosiderosis. Baillieres Clin Haematol 1994;7:919-940.
2. Brittenham GM, Griffith PM, Nienhuis AW, et al. Efficacy of deferoxamine in preventing complications of iron overload in patients with thalassemia major. N Engl J Med 1994:331:567-573.
3. Borgna-Pignatti C, Castriota-Scanderbeg A. Methods for evaluating iron stores and efficacy of chelation in transfusional hemosiderosis. Haematologica 1991:76:409-413.
4. Angelucci E, Baronciani D, Lucarelli G, et al. Needle liver biopsy in thalassaemia: analyses of diagnostic accuracy and safety in 1184 consecutive biopsies. Br J Haematol 1995:89:757-761.
5. Crisponi G, Ambu R, Cristiani F, et al. Does iron concentration in a liver needle biopsy accurately reflect hepatic iron burden in beta-thalassemia? Clin Chem 2000;46:1185-1188.
6. Kaltwasser JP, Gottschalk R, Schalk KP, Hartl W. Non-invasive quantitation of liver iron-overload by magnetic resonance imaging. Br J Haematol 1990;74:360-363.
7. Bonkovsky HL, Slaker DP, Bills EB, Wolf DC. Usefulness and limitations of laboratory and hepatic imaging studies in iron-storage disease. Gastroenterology 1990;99:1079-1091.
8. Papakonstantinou OG, Maris TG, Kostaridou V, et al. Assessment of liver iron overload by T2-quantitative magnetic resonance imaging: correlation of T2-QMRI measurements with serum ferritin concentration and histologic grading of siderosis. Magn Reson Imaging 1995;13:967-977.
9. Chan YL, Li CK, Lam CW, et al. Liver iron estimation in beta-thalassaemia: comparison of MRI biochemical assay and histological grading. Clin Radiol 2001;56:911-916.
10. Gomori JM, Horev G, Tamary H, et al. Hepatic iron overload: quantitative MR imaging. Radiology 1991;179:367-369.
11. Gandon Y, Olivie D, Guyader D, et al. Non-invasive assessment of hepatic iron stores by MRI. Lancet 2004;363:357-362.
12. Alustiza JM, Artetxe J, Castiella A, et al. MR quantification of hepatic iron concentration. Radiology 2004;230:479-484.
13. Bonkovsky HL, Rubin RB, Cable EE, Davidoff A, RijckenTH, Stark DD. Hepatic iron concentration: noninvasive estimation by means of MR imaging techniques. Radiology 1999;212:227-234.
14. Rocchi E, Cassanelli M, Borghi A, et al. Magnetic resonance imaging and different levels of iron overload in chronic liver disease. Hepatology 1993;17:997-1002.
15. Mavrogeni SI, Gotsis ED, Markussis V, et al. T2 relaxation time study of iron overload in b-thalassemia. MAGMA 1998;6:7-12.
16. Angelucci E, Giovagnoni A, Valeri G, et al. Limitations of magnetic resonance imaging in measurement of hepatic iron. Blood 1997;90:4736-4742.
17. Anderson LJ, Holden S, Davis B, et al. Cardiovascular T2-star (T2*) magnetic resonance for the early diagnosis of myocardial iron overload. Eur Heart J 2001;22:2171-2179.
18. Anderson LJ, Wonke B, Prescott E, Holden S, Walker JM, Pennell DJ. Comparison of effects of oral deferiprone and subcutaneous desferrioxamine on myocardial iron concentrations and ventricular function in beta-thalassaemia. Lancet 2002;360:516-520.
19. Voskaridou E, Douskou M, Terpos E, et al. Magnetic resonance imaging in the evaluation of iron overload in patients with beta thalassaemia and sickle cell disease. Br J Haematol 2004;126:736-742.
20. St Pierre TG, Clark PR, Chua-Anusorn W, et al. Noninvasive measurement and imaging of liver iron concentrations using proton magnetic resonance. Blood 2005;105:855-861.
21. Westwood M, Anderson LJ, Firmin DN, et al. A single breath-hold multiecho T2* cardiovascular magnetic resonance technique for diagnosis of myocardial iron overload. J Magn Reson Imaging 2003;18:33-39.
22. Westwood MA, Anderson LJ, Firmin DN, et al. Interscanner reproducibility of cardiovascular magnetic resonance T2* measurements of tissue iron in thalassemia. J Magn Reson Imaging 2003;18:616-620.
23. Papanikolaou N, Ghiatas A, Kattamis A, Ladis C, Kritikos N, Kattamis C. Non-invasive myocardial iron assessment in thalassaemic patients. T2 relaxometry and magnetization transfer ratio measurements. Acta Radiol 2000;41:348-351.
24. Argyropoulou MI, Kiortsis DN, Efremidis SC. MRI of the liver and the pituitary gland in patients with beta-thalassemia major: does hepatic siderosis predict pituitary iron deposition? Eur Radiol 2003;13:12-16.
25. Siegelman ES, Mitchell DG, Semelka RC. Abdominal iron deposition: metabolism, MR findings, and clinical importance. Radiology 1996;199:13-22.
26. Reichenbach JR, Hacklander T, Harth T, Hofer M, Rassek M, Modder U. IH T1 and T2 measurements of the MR imaging contrast agents Gd-DTPA and Gd-DTPA BMA at 1.5T. Eur Radiol 1997;7:264-274.
27. Ishak K, Baptista A, Bianchi L, et al. Histological grading and staging of chronic hepatitis. J Hepatol 1995;22:696-699.
28. Scheuer PJ. Iron storage disease. In: MacSween RNM, Anthony PP, Scheuer PJ, Burt AD, Portmann BC, editors. Pathology of the liver. 3rd ed. Edinburgh/New York: Churchill Livingstone; 1994. p 223-242.
29. Lepag M, Jayasakera PM, Back SA, Baldock C. Dose resolution optimization of polymer gel dosimeters using different monomers. Phys Med Biol 2001;46:2665-2680.
30. De Deene Y, Van de Walle R, Achten E, De Wagter C. Mathematical analysis and experimental investigation of noise in quantitative magnetic resonance imaging applied in polymer gel dosimetry. Signal Processing 1998;70:85-101.
31. Wood JC, Otto-Duessel M, Aguilar M, et al. Cardiac iron determines cardiac T2*. T2, and T1 in the gerbil model of iron cardiomyopathy. Circulation 2005;112:535-543.
32. Stark DD, Bass NM, Moss AA, et al. Nuclear magnetic resonance imaging of experimentally induced liver disease. Radiology 1983;148:743-751.
33. Wang ZJ, Haselgrove JC, Martin MB, et al. Evaluation of iron overload by single voxel MRS measurement of liver T2. J Magn Reson Imaging 2002;15:395-400.